Accolade, Inc. (NASDAQ:ACCD) Given Average Rating of "Hold" by Brokerages

Shares of Accolade, Inc. (NASDAQ:ACCD - Get Free Report) have been given a consensus rating of "Hold" by the fourteen brokerages that are presently covering the company, MarketBeat Ratings reports. Thirteen analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $6.51.

A number of research analysts recently issued reports on ACCD shares. Leerink Partners reaffirmed a "market perform" rating on shares of Accolade in a report on Wednesday, January 8th. Leerink Partnrs lowered shares of Accolade from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, January 8th. Stephens reissued an "equal weight" rating and issued a $7.03 price target on shares of Accolade in a report on Wednesday, February 12th. Raymond James reaffirmed a "market perform" rating on shares of Accolade in a report on Thursday, January 9th. Finally, Canaccord Genuity Group reissued a "hold" rating on shares of Accolade in a research note on Wednesday, January 8th.

Hedge Funds Weigh In On Accolade

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. D. E. Shaw & Co. Inc. raised its stake in Accolade by 77.9% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,280,783 shares of the company's stock worth $7,800,000 after buying an additional 998,423 shares during the period. Fairman Group LLC raised its position in shares of Accolade by 58.5% during the fourth quarter. Fairman Group LLC now owns 1,802,399 shares of the company's stock worth $6,164,000 after purchasing an additional 665,112 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Accolade by 4.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,038 shares of the company's stock valued at $6,862,000 after purchasing an additional 83,556 shares in the last quarter. Whetstone Capital Advisors LLC grew its position in shares of Accolade by 58.9% in the 4th quarter. Whetstone Capital Advisors LLC now owns 1,585,643 shares of the company's stock valued at $5,423,000 after purchasing an additional 587,754 shares during the period. Finally, Clearline Capital LP increased its stake in Accolade by 85.3% during the 3rd quarter. Clearline Capital LP now owns 1,539,578 shares of the company's stock worth $5,927,000 after purchasing an additional 708,794 shares in the last quarter. 84.99% of the stock is owned by institutional investors.

Remove Ads

Accolade Price Performance

Shares of NASDAQ:ACCD traded up $0.01 on Monday, hitting $7.00. The stock had a trading volume of 73,846 shares, compared to its average volume of 1,397,345. The company has a market capitalization of $573.95 million, a price-to-earnings ratio of -3.11 and a beta of 2.18. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.63 and a current ratio of 2.63. The firm's 50 day moving average price is $6.94 and its 200-day moving average price is $5.02. Accolade has a twelve month low of $3.08 and a twelve month high of $9.67.

Accolade (NASDAQ:ACCD - Get Free Report) last posted its quarterly earnings data on Friday, January 10th. The company reported ($0.30) earnings per share for the quarter, topping the consensus estimate of ($0.31) by $0.01. Accolade had a negative net margin of 40.36% and a negative return on equity of 20.74%. On average, equities research analysts predict that Accolade will post -1.2 earnings per share for the current year.

About Accolade

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians.